financetom
Business
financetom
/
Business
/
Proto Labs Q3 Non-GAAP Earnings Flat, Revenue Rises; Q4 Outlook Set
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Proto Labs Q3 Non-GAAP Earnings Flat, Revenue Rises; Q4 Outlook Set
Oct 31, 2025 3:39 AM

06:19 AM EDT, 10/31/2025 (MT Newswires) -- Proto Labs ( PRLB ) reported Q3 non-GAAP earnings Friday of $0.47 per diluted share, unchanged from a year earlier.

Analysts surveyed by FactSet expected $0.39.

Total revenue for the quarter ended Sept. 30 was $135.4 million, up from $125.6 million a year earlier.

Analysts surveyed by FactSet expected $133.9 million.

The company said it expects Q4 non-GAAP diluted EPS in the range of $0.30 to $0.38. Analysts polled by FactSet expect $0.34.

Revenue for the quarter is expected to be in the range of $125 million to $133 million. Analysts surveyed by FactSet expect $129.1 million.

Shares of the company were up almost 1% in recent Friday premarket activity.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Britain's IAG to order around 30 Airbus jets, sources say
Britain's IAG to order around 30 Airbus jets, sources say
May 26, 2025
LONDON/PARIS, May 8 (Reuters) - British Airways owner IAG plans to place an order for around 30 long-haul jets from Airbus as part of a wide-body order split between the European planemaker and its U.S. rival Boeing ( BA ) , industry sources said on Thursday. The order, which includes A330neo and A350 models, is expected to be announced with...
Novavax says talks with FDA on COVID vaccine approval ongoing calming investor fears
Novavax says talks with FDA on COVID vaccine approval ongoing calming investor fears
May 26, 2025
(Reuters) -Novavax ( NVAX ) on Thursday tried to calm investors spooked by the delay of full approval of its COVID vaccine shot by U.S. regulators saying that it sees a pathway to resolving issues with the FDA, sending shares up nearly 19% in early trading. The vaccine maker said it believes commitments to run new trials would be after...
Carlyle Shares Rise After Q1 Results
Carlyle Shares Rise After Q1 Results
May 26, 2025
02:31 PM EDT, 05/08/2025 (MT Newswires) -- Carlyle Group ( CG ) shares were up more than 4% in recent trading Thursday following its Q1 results. Earlier, the private equity firm reported Q1 net income of $0.35 per share, up from $0.18 a year earlier. Two analysts polled by FactSet expected $1.05. It posted after-tax distributable earnings of $1.14 per...
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
Copyright 2023-2026 - www.financetom.com All Rights Reserved